Nexgel Inc

Company Profile

Nexgel Inc had its IPO on 2021-12-22 under the ticker symbol NXGL.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Nexgel Inc has a staff strength of 12 employees.

Stock update

Shares of Nexgel Inc opened at $2.35 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.16 - $2.45, and closed at $2.32.

This is a +2.65% increase from the previous day's closing price.

A total volume of 17,892 shares were traded at the close of the day’s session.

In the last one week, shares of Nexgel Inc have slipped by -7.94%.

Nexgel Inc's Key Ratios

Nexgel Inc has a market cap of $14.35 million, indicating a price to book ratio of 0.8815 and a price to sales ratio of 4.253.

In the last 12-months Nexgel Inc’s revenue was $2.88 million with a gross profit of $256000 and an EBITDA of $-3341000. The EBITDA ratio measures Nexgel Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Nexgel Inc’s operating margin was -120.36% while its return on assets stood at -17.84% with a return of equity of -41.32%.

In Q2, Nexgel Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 108%.

Nexgel Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.64 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nexgel Inc’s profitability.

Nexgel Inc stock is trading at a EV to sales ratio of 0.9499 and a EV to EBITDA ratio of -0.5565. Its price to sales ratio in the trailing 12-months stood at 4.253.

Nexgel Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$10.50 million

Total Liabilities

$1.67 million

Operating Cash Flow

$0

Capital Expenditure

$165000

Dividend Payout Ratio

0%

Nexgel Inc ended 2024 with $10.50 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.50 million while shareholder equity stood at $6.18 million.

Nexgel Inc ended 2024 with $0 in deferred long-term liabilities, $1.67 million in other current liabilities, 6000.00 in common stock, $-13067000.00 in retained earnings and $311000.00 in goodwill. Its cash balance stood at $3.69 million and cash and short-term investments were $4.30 million. The company’s total short-term debt was $247,000 while long-term debt stood at $265000.00.

Nexgel Inc’s total current assets stands at $6.70 million while long-term investments were $0 and short-term investments were $612000.00. Its net receivables were $950000.00 compared to accounts payable of $1.06 million and inventory worth $1.08 million.

In 2024, Nexgel Inc's operating cash flow was $0 while its capital expenditure stood at $165000.

Comparatively, Nexgel Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.32

52-Week High

$3.05

52-Week Low

$1.09

Analyst Target Price

$5

Nexgel Inc stock is currently trading at $2.32 per share. It touched a 52-week high of $3.05 and a 52-week low of $3.05. Analysts tracking the stock have a 12-month average target price of $5.

Its 50-day moving average was $2.2 and 200-day moving average was $1.78 The short ratio stood at 3.29 indicating a short percent outstanding of 0%.

Around 2416.8% of the company’s stock are held by insiders while 164.7% are held by institutions.